← back to search

Christoph Henzen

Solothurner Spitäler · CH
Area of research
Endocrinology, Diabetes and Metabolism · Physiology
Research interest
Research interests include Adrenal Hormones and Disorders, Nutrition and Health in Aging, Sepsis Diagnosis and Treatment, and Frailty in Older Adults.
h-index
38
citations
6,788
works
165
NIH funding
primary concept
Medicine
email

Recent publications

Association of CT-based diagnosis of sarcopenia with prognosis and treatment response in patients at risk of malnutrition - A secondary analysis of the Effect of early nutritional support on Frailty, Functional Outcomes, and Recovery of malnourished medical inpatients Trial (EFFORT) trial.
2023cited by 16position: contributordoi
Validation of modified GLIM criteria to predict adverse clinical outcome and response to nutritional treatment: A secondary analysis of a randomized clinical trial.
2022cited by 41position: contributordoi
Prospective validation of five malnutrition screening and assessment instruments among medical inpatients: Secondary analysis of a randomized clinical trial.
2022cited by 15position: contributordoi
Admission kidney function is a strong predictor for the response to nutritional support in patients at nutritional risk.
2021cited by 40position: contributordoi
Six-month outcomes after individualized nutritional support during the hospital stay in medical patients at nutritional risk: Secondary analysis of a prospective randomized trial.
2021cited by 40position: contributordoi
Effect of nutritional support in patients with lower respiratory tract infection: Secondary analysis of a randomized clinical trial.
2021cited by 25position: contributordoi
The impact of nutritional support on malnourished inpatients with aging-related vulnerability.
2021cited by 24position: contributordoi
Fear of Falling, Recurrence of Falls, and Quality of Life in Patients with a Low Energy Fracture-Part II of an Observational Study.
2021cited by 8position: contributordoi
Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial
The Lancet 2019cited by 862position: middledoi
Long-Term Effects of Initiating Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM) in People with Type 1 Diabetes and Unsatisfactory Diabetes Control.
2019cited by 12position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 9 papers (2019–2023)Philipp Schüetz · Kantonsspital Aarau7 papers (2021–2023)Robert V. Thomann · Schweizerische Ärztegesellschaft für Psycholytische Therapie6 papers (2021–2023) · 6 papers (2021–2023)Filomena Gomes · Hospital de Santo António6 papers (2021–2022) · 6 papers (2021–2023)Nicolas Rodondi · Hôpital régional5 papers (2021–2023)Philipp Schuetz · 5 papers (2021–2023) · 5 papers (2021–2023) · 4 papers (2021–2021) · 4 papers (2021–2022)Beat Müeller · Kantonsspital Aarau4 papers (2021–2021) · 3 papers (2021–2021)Jacques Donzé · 3 papers (2021–2022)Michael Brändle · Vanderbilt University Medical Center2 papers (2022–2022)Alexander Kutz · RELX Group (United States)2 papers (2021–2022)Stefan Bilz · Endokrinologikum2 papers (2022–2022) · 2 papers (2022–2022)Annic Baumgartner · 2 papers (2021–2023) · 2 papers (2022–2022)